310 related articles for article (PubMed ID: 28681829)
1. Molecular characterisation of uropathogenic
Chakraborty A; Adhikari P; Shenoy S; Saralaya V
Indian J Med Microbiol; 2017; 35(2):305-310. PubMed ID: 28681829
[TBL] [Abstract][Full Text] [Related]
2. Lower prevalence of hlyD, papC and cnf-1 genes in ciprofloxacin-resistant uropathogenic Escherichia coli than their susceptible counterparts isolated from southern India.
Harwalkar A; Gupta S; Rao A; Srinivasa H
J Infect Public Health; 2014; 7(5):413-9. PubMed ID: 24861644
[TBL] [Abstract][Full Text] [Related]
3. Virulence genes and phylogenetic groups of uropathogenic Escherichia coli isolates from patients with urinary tract infection and uninfected control subjects: a case-control study.
Rezatofighi SE; Mirzarazi M; Salehi M
BMC Infect Dis; 2021 Apr; 21(1):361. PubMed ID: 33865334
[TBL] [Abstract][Full Text] [Related]
4. Detection of virulence genes, phylogenetic group and antibiotic resistance of uropathogenic Escherichia coli in Mongolia.
Munkhdelger Y; Gunregjav N; Dorjpurev A; Juniichiro N; Sarantuya J
J Infect Dev Ctries; 2017 Jan; 11(1):51-57. PubMed ID: 28141590
[TBL] [Abstract][Full Text] [Related]
5. Snapshot of Phylogenetic Groups, Virulence, and Resistance Markers in
Cristea VC; Gheorghe I; Czobor Barbu I; Popa LI; Ispas B; Grigore GA; Bucatariu I; Popa GL; Angelescu MC; Velican A; Marutescu L; Popa M; Chifiriuc MC; Popa IM
Biomed Res Int; 2019; 2019():5712371. PubMed ID: 31236408
[TBL] [Abstract][Full Text] [Related]
6. Multiple antibiotic resistances and virulence markers of uropathogenic Escherichia coli from Mexico.
Paniagua-Contreras GL; Monroy-Pérez E; Bautista A; Reyes R; Vicente A; Vaca-Paniagua F; Díaz CE; Martínez S; Domínguez P; García LR; Uribe-García A; Vaca S
Pathog Glob Health; 2018 Dec; 112(8):415-420. PubMed ID: 30433859
[TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil.
Moreira da Silva RCR; de Oliveira Martins Júnior P; Gonçalves LF; de Paulo Martins V; de Melo ABF; Pitondo-Silva A; de Campos TA
J Glob Antimicrob Resist; 2017 Jun; 9():61-67. PubMed ID: 28419868
[TBL] [Abstract][Full Text] [Related]
8. Characterization of auto-agglutinating and non-typeable uropathogenic Escherichia coli strains.
Hernández-Chiñas U; Pérez-Ramos A; Belmont-Monroy L; Chávez-Berrocal ME; González-Villalobos E; Navarro-Ocaña A; Eslava CA; Molina-Lopez J
J Infect Dev Ctries; 2019 Jun; 13(6):465-472. PubMed ID: 32058980
[TBL] [Abstract][Full Text] [Related]
9. Genomic analysis and clinical importance of Escherichia coli isolate from patients with sepsis.
Chakraborty A; Adhikari P; Shenoy S; Saralaya V
Indian J Pathol Microbiol; 2015; 58(1):22-6. PubMed ID: 25673586
[TBL] [Abstract][Full Text] [Related]
10. Phylogeny, sequence-typing and virulence profile of uropathogenic Escherichia coli (UPEC) strains from Pakistan.
Ali I; Rafaque Z; Ahmed I; Tariq F; Graham SE; Salzman E; Foxman B; Dasti JI
BMC Infect Dis; 2019 Jul; 19(1):620. PubMed ID: 31299909
[TBL] [Abstract][Full Text] [Related]
11. Virulence traits and pathogenicity of uropathogenic Escherichia coli isolates with common and uncommon O serotypes.
Gao Q; Zhang D; Ye Z; Zhu X; Yang W; Dong L; Gao S; Liu X
Microb Pathog; 2017 Mar; 104():217-224. PubMed ID: 28104383
[TBL] [Abstract][Full Text] [Related]
12. Virulence genes, quinolone and fluoroquinolone resistance, and phylogenetic background of uropathogenic Escherichia coli strains isolated in Japan.
Kawamura-Sato K; Yoshida R; Shibayama K; Ohta M
Jpn J Infect Dis; 2010 Mar; 63(2):113-5. PubMed ID: 20332573
[TBL] [Abstract][Full Text] [Related]
13. Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa, Ethiopia.
Dadi BR; Abebe T; Zhang L; Mihret A; Abebe W; Amogne W
BMC Infect Dis; 2020 Feb; 20(1):108. PubMed ID: 32033541
[TBL] [Abstract][Full Text] [Related]
14. Significant association between genes encoding virulence factors with antibiotic resistance and phylogenetic groups in community acquired uropathogenic Escherichia coli isolates.
Yazdanpour Z; Tadjrobehkar O; Shahkhah M
BMC Microbiol; 2020 Aug; 20(1):241. PubMed ID: 32758126
[TBL] [Abstract][Full Text] [Related]
15. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children.
Yun KW; Kim HY; Park HK; Kim W; Lim IS
J Microbiol Immunol Infect; 2014 Dec; 47(6):455-61. PubMed ID: 24064288
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of virulence factors and phylogenetic characterization of uropathogenic Escherichia coli causing urinary tract infection in patients with and without diabetes mellitus.
Harwalkar A; Gupta S; Rao A; Srinivasa H
Trans R Soc Trop Med Hyg; 2015 Dec; 109(12):769-74. PubMed ID: 26567223
[TBL] [Abstract][Full Text] [Related]
17. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH
Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617
[TBL] [Abstract][Full Text] [Related]
18. Association between TLR4 polymorphisms (896 A>G, 1196 C>T, - 2570 A>G, - 2081 G>A) and virulence factors in uropathogenic Escherichia coli.
Castro-Alarcón N; Rodríguez-García R; Ruíz-Rosas M; Muñoz-Valle JF; Guzmán-Guzmán IP; Parra-Rojas I; Vázquez-Villamar M
Clin Exp Med; 2019 Feb; 19(1):105-113. PubMed ID: 30220001
[TBL] [Abstract][Full Text] [Related]
19. Distribution of virulence genes and their association with antimicrobial resistance among uropathogenic Escherichia coli isolates from Iranian patients.
Malekzadegan Y; Khashei R; Sedigh Ebrahim-Saraie H; Jahanabadi Z
BMC Infect Dis; 2018 Nov; 18(1):572. PubMed ID: 30442101
[TBL] [Abstract][Full Text] [Related]
20. Molecular Analysis of Uropathogenic E.coli Isolates from Urinary Tract Infections.
Valadbeigi H; Esmaeeli E; Ghafourian S; Maleki A; Sadeghifard N
Infect Disord Drug Targets; 2019; 19(3):322-326. PubMed ID: 30421685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
